Drug intelligence / Profile preview

hTERT-siRNA

Development stage
Preclinical
Lead developer
Jiangsu Provincial People's Hospital
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

hTERT-siRNA is a small interfering RNA (siRNA) therapeutic approach designed to silence the expression of human telomerase reverse transcriptase (hTERT). hTERT is the catalytic subunit of the telomerase enzyme, which is critical for maintaining telomere length and is frequently upregulated in various cancers, including glioblastoma, to facilitate cellular immortality. By utilizing the RNA interference (RNAi) pathway, hTERT-siRNA mediates the sequence-specific degradation of hTERT mRNA, thereby inhibiting telomerase activity. This inhibition leads to telomere shortening, induction of the DNA damage response, cell cycle arrest (typically in the G1/G0 phase), and apoptosis. Research has demonstrated that knockdown of hTERT via siRNA, often delivered through viral vectors like lentivirus, can significantly inhibit tumor cell growth and sensitize cells to other treatments.

Other names
human telomerase reverse transcriptase small interfering RNA
02

Targets

TERT (Telomerase)

Beyond the preview

Go deeper on hTERT-siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hTERT-siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call